Dementia With Lewy Bodies Is Far More Common Than Diagnosed, Meta-Analysis Finds
A major meta-analysis reveals DLB incidence rises steeply with age and is higher in men, but widespread underdiagnosis distorts true burden.
Summary
A systematic review and meta-analysis published in JAMA Neurology pooled data from 16 population-based studies to generate the first robust global estimates of dementia with Lewy bodies (DLB) incidence and prevalence. In adults 65 and older, the pooled incidence was roughly 47 cases per 100,000 person-years and prevalence about 352 per 100,000. Rates were dramatically lower in those under 65. Men were diagnosed more often than women. However, researchers caution that these figures almost certainly undercount true cases due to poor diagnostic sensitivity and inconsistent criteria across studies. High between-study variability further complicates interpretation. The findings establish a critical epidemiological baseline and highlight an urgent need for standardized diagnostic tools and broader population inclusion to accurately capture the global burden of this often-missed neurodegenerative disease.
Detailed Summary
Dementia with Lewy bodies (DLB) is the second most common form of degenerative dementia after Alzheimer's disease, yet reliable global estimates of its frequency have been largely absent. Without solid epidemiological data, it is difficult to allocate healthcare resources, design clinical trials, or develop public health strategies targeting this condition. This meta-analysis aimed to fill that gap.
Researchers systematically searched PubMed, Embase, and Scopus through October 2024, identifying 2,520 records and ultimately including 16 population-based studies in the review, with 12 contributing quantitative data to meta-analyses. Studies were required to use validated diagnostic criteria for DLB, and risk of bias was assessed using PRISMA guidelines. Random-effects models were used to pool estimates across heterogeneous study populations.
In adults aged 65 and older, pooled incidence reached 46.85 cases per 100,000 person-years and pooled prevalence was 352.26 per 100,000 — figures that rise steeply with advancing age. In those under 65, both rates were dramatically lower (incidence 0.34; prevalence 2.52 per 100,000). Male sex was associated with higher incidence. Across all ages, the crude pooled incidence was 4.79 per 100,000 person-years. Between-study heterogeneity was high (I² ≥ 85%), indicating substantial variability across settings and study designs.
The authors interpret the relatively low observed rates as likely reflecting significant underdiagnosis rather than true rarity. DLB shares clinical features with Alzheimer's and Parkinson's disease, making accurate diagnosis challenging, particularly outside of specialty centers. Many community-based studies may miss cases entirely.
For clinicians and public health planners, these findings underscore that DLB is a meaningful and likely underappreciated contributor to dementia burden globally, particularly in older men. Standardized diagnostic protocols and inclusion of underrepresented populations in future research are essential to refine these estimates and guide care planning.
Key Findings
- In adults 65+, DLB pooled incidence is ~47 per 100,000 person-years; prevalence ~352 per 100,000.
- DLB incidence is roughly 5x higher in adults 65+ versus those under 65.
- Male incidence (5.45 per 100,000) is higher than female incidence (4.32 per 100,000).
- High between-study heterogeneity (I² ≥ 85%) suggests actual burden may vary widely by region.
- Low observed rates likely reflect widespread underdiagnosis rather than true rarity of DLB.
Methodology
This was a systematic review and meta-analysis of 16 population-based studies sourced from PubMed, Embase, and Scopus through October 2024. Only studies using validated DLB diagnostic criteria were included, and random-effects models were used to pool incidence and prevalence estimates. Subgroup analyses explored variation by age and sex.
Study Limitations
Between-study heterogeneity was very high (I² ≥ 85%), limiting confidence in pooled estimates. The summary is based on the abstract only, so full methodological detail and sensitivity analysis results are unavailable. Estimates almost certainly underrepresent true prevalence due to diagnostic insensitivity and underrepresentation of non-Western and rural populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.